Hormone replacement therapy and the incidence and prevalence of breast cancer: an integrative review
Terapia de reposição hormonal e a incidência e prevalência de câncer de mama: uma revisão integrativa
DOI:
https://doi.org/10.53660/CLM-3342-24H50Palavras-chave:
Breast neoplasms, Menopause, Hormone replacement therapyResumo
The objective of this study was to carry out an integrative review an integrative review to analyze the incidence and prevalence of breast cancer after hormone replacement therapy. This integrative review followed several steps, including identifying the topic, structuring the research question using the PICO strategy, defining inclusion criteria, selecting articles, evaluating and analyzing selected studies, interpreting the results and presenting the review. The use of hormone replacement therapy (HRT) is linked to a significantly increased risk of breast cancer, especially with combination therapy. The risk increases with time of use and persists after discontinuation. Although some studies have found a significant risk, estrogen-only therapy carries a lower risk, particularly for long-term use. Hormone replacement therapy, especially the combined formulation of estrogen and progestogen, is associated with a significant increase in the risk of breast cancer, persisting after discontinuation. The estrogen-only formulation has a lower risk. The duration of HRT and body mass index (BMI) also influence the risk.
Downloads
Referências
ABEDZADEH KALARHOUDI, M. et al. Assessment of quality of life in menopausal periods: a population study in kashan, iran. Iranian Red Crescent medical journal, v. 13, n. 11, p. 811–7, nov. 2011.
BRASIL. Manual de Atencao à Mulher no Climatério/Menopausa. [s.l: s.n.].
CENTRO PROVINCIAL DE INFORMACIÓN DE CIENCIAS MÉDICAS (CUBA), D.; NÁPOLES MÉNDEZ, D. Medisan. [s.l.] Centro Provincial de Información de Ciencias Médicas, 2014. v. 18
CORDINA-DUVERGER, E. et al. Risk of breast cancer by type of menopausal hormone therapy: A case-control study among post-menopausal women in France. PLoS ONE, v. 8, n. 11, 2013a.
DE LORENZI, D. R. S. Avaliação da qualidade de vida no climatério. Revista Brasileira de Ginecologia e Obstetricia, 2008.
FAUBION, S. S. et al. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, v. 29, n. 7, p. 767–794, 1 jul. 2022.
FREITAS, E. R.; BARBOSA, A. J. G. Arquivos brasileiros de psicologia. [s.l.] Univ, 2015. v. 67
GALE GROUP., M. T. et al. Revista aletheia. [s.l.] Universidade Luterana do Brasil, 2018. v. 51
HOU, N. et al. Hormone replacement therapy and breast cancer: Heterogeneous risks by race, weight, and breast density. Journal of the National Cancer Institute, v. 105, n. 18, 2013.
KAUNITZ, A. M.; MANSON, J. E. Management of menopausal symptoms. Obstetrics and Gynecology, v. 126, n. 4, 2015.
LEE, S. R. et al. The 2020 Menopausal Hormone Therapy Guidelines. Journal of Menopausal Medicine, v. 26, n. 2, p. 69, 2020.
LI, C. I. et al. Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55-74 years of age. Breast Cancer Research and Treatment, v. 145, n. 2, 2014a.
LIU, J. Y.; CHEN, T. J.; HWANG, S. J. The risk of breast cancer in women using menopausal hormone replacement therapy in Taiwan. International Journal of Environmental Research and Public Health, v. 13, n. 5, 11 maio 2016a.
MANICA, J.; BELLAVER, E. H.; ZANCANARO, V. Efeitos das terapias na menopausa: uma revisão narrativa da literatura. Journal of Health & Biological Sciences, v. 7, n. 1(Jan-Mar), 2018.
MANSON, J. A. E. et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the women’s health initiative randomized trials. JAMA, v. 310, n. 13, 2013.
MARTINS, S. C. et al. Hormone Therapy and Breast Cancer: a literature review about the influence of hormonal treatment on neoplastic development. REVISTA MÉDICA DE MINAS GERAIS, v. 31, 2021.
MINISTÉRIO DA SAÚDE. Menopausa e Climatério. Disponível em: <https://bvsms.saude.gov.br/menopausa-e-climaterio/#:~:text=A%20menopausa%20corresponde%20ao%20%C3%BAltimo,de%20menopausa%20prematura%20ou%20precoce.>. Acesso em: 27 out. 2023.
PEDRO, A. O. et al. Procura de serviço médico por mulheres climatéricas brasileiras. Revista de Saúde Pública, v. 36, n. 4, 2002.
PFIZER. Terapia de Reposição Hormonal. Disponível em: . Acesso em: 7 fev. 2024.
SIMIN, J. et al. Menopausal hormone therapy and cancer risk: An overestimated risk? European Journal of Cancer, v. 84, 2017a.
SUHRKE, P.; ZAHL, P. H. Breast cancer incidence and menopausal hormone therapy in Norway from 2004 to 2009: A register-based cohort study. Cancer Medicine, v. 4, n. 8, 2015a.
TAYLOR, H. S.; MANSON, J. A. E. Update in hormone therapy use in menopause. Journal of Clinical Endocrinology and Metabolism, 2011.
UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO. FACULTAD DE MEDICINA., E. A. et al. Revista de la Facultad de Medicina, Universidad Nacional Autónoma de México. [s.l.] Universidad Nacional Autónoma de México, Facultad de Medicina, 2012. v. 55
VINOGRADOVA, Y.; COUPLAND, C.; HIPPISLEY-COX, J. Use of hormone replacement therapy and risk of breast cancer: Nested case-control studies using the QResearch and CPRD databases. The BMJ, v. 371, 2020.
